billHR7863Monday, March 9, 2026Analyzed

To amend title XVIII of the Social Security Act to align payment under Medicare for specified surgical procedures with high-cost supplies furnished in office-based facilities, and for other purposes.

Neutral
Impact4/10

Summary

HR7863, the 'Promoting Fairness for Medicare Providers Act of 2026,' aims to increase Medicare reimbursement rates for specific high-cost surgical procedures performed in office-based facilities starting in 2027. This bill is currently in the early stages of the legislative process, having been introduced and referred to two committees on March 9, 2026.

Key Takeaways

  • 1.HR7863 proposes to increase Medicare reimbursement rates for specific high-cost surgical procedures in office-based facilities starting in 2027.
  • 2.The bill is in the early stages of the legislative process, having been referred to two House committees.
  • 3.Companies like Tenet Healthcare Corporation ($THC), HCA Healthcare, Inc. ($HCA), and Universal Health Services, Inc. ($UHS) could structurally benefit if the bill becomes law.

Market Implications

The 'Promoting Fairness for Medicare Providers Act of 2026' (HR7863) aims to enhance the financial viability of outpatient surgical centers and diagnostic service providers by increasing Medicare reimbursement rates for specific high-cost surgical procedures. While the bill is in its early legislative stages, its eventual passage would directly improve revenue streams for operators of these facilities. Companies such as Tenet Healthcare Corporation ($THC), HCA Healthcare, Inc. ($HCA), and Universal Health Services, Inc. ($UHS), which have significant outpatient operations, are positioned to benefit from this regulatory change. Currently, the market performance of these companies shows mixed short-term trends against a backdrop of monthly declines. Tenet Healthcare Corporation ($THC) is at $190.28, HCA Healthcare, Inc. ($HCA) at $483.92, and Universal Health Services, Inc. ($UHS) at $181.33. The early stage of HR7863 and its future effective date mean that current market prices are not reflecting this potential future benefit. Investors should monitor the bill's progress through Congress for future implications.

Full Analysis

HR7863, titled the 'Promoting Fairness for Medicare Providers Act of 2026,' was introduced in the House of Representatives on March 9, 2026, by Rep. Bilirakis (R-FL-12) and referred to the Committees on Energy and Commerce and Ways and Means. The bill proposes to amend the Social Security Act to align Medicare payment for specified surgical procedures with high-cost supplies furnished in office-based facilities, with changes effective starting in 2027. This legislative action is in its initial phase, requiring committee consideration before any further progress. The bill does not specify a direct funding amount but rather modifies the payment structure for existing Medicare reimbursements. The mechanism involves increasing the payment amount for facility services furnished in connection with specified high supply cost surgical procedures in office-based facilities. This represents a regulatory adjustment to reimbursement rates, directly enhancing the revenue potential for providers of these services. The bill aims to improve the financial viability of outpatient surgical centers and diagnostic service providers by increasing the amounts paid by Medicare for these specific procedures. Structural beneficiaries of this bill, if enacted, would be companies operating or managing outpatient surgical centers and diagnostic service providers. While AMN Healthcare Services, Inc. ($AMN) focuses on healthcare staffing, Tenet Healthcare Corporation ($THC), HCA Healthcare, Inc. ($HCA), and Universal Health Services, Inc. ($UHS) operate numerous hospitals and outpatient facilities that could benefit from increased Medicare reimbursement rates for specified procedures. SurgePays, Inc. ($SURG) is not directly related to this type of healthcare service provision. Looking at recent market data, Tenet Healthcare Corporation ($THC) has seen a 7-day change of +1.21% but a 30-day change of -21.18%, currently trading at $190.28. HCA Healthcare, Inc. ($HCA) shows a 7-day change of +3.44% and a 30-day change of -9.46%, with a current price of $483.92. Universal Health Services, Inc. ($UHS) has a 7-day change of -0.42% and a 30-day change of -7.94%, trading at $181.33. These companies have experienced recent declines over the past month, despite some positive movement in the last week. The legislative steps remaining include committee review, potential markups, votes in the House, and then the same process in the Senate, followed by presidential assent. Given the early stage of the bill, its impact on current market prices is not yet observable. The bill's effective date of 2027 means any financial benefits for providers would be realized in the future, assuming passage. The current market performance of these healthcare providers reflects broader market dynamics rather than direct influence from this specific bill.

Market Impact Score

4/10
Minimal ImpactModerateMajor Market Event